TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31882008

Group type: EXPERIMENTAL
Intervention: Robot-assisted walking (RAW)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unassisted walking (UAW)
Number of subjects: 12
Study: 28730849

Group type: EXPERIMENTAL
Intervention: Treadmill training plus normal gait re-education
Number of subjects: 77

Group type: COMPARATOR
Intervention: Normal gait re-education only (control)
Number of subjects: 77
Study: 26909493

Group type: EXPERIMENTAL
Intervention: PMEA-coated circuits
Number of subjects: 20

Group type: COMPARATOR
Intervention: Heparin-coated circuits
Number of subjects: 20
Study: 25244402

Group type: EXPERIMENTAL
Intervention: Gatifloxacin 0.5%
Number of subjects: 1437

Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 1437
Study: 22993919

Group type: EXPERIMENTAL
Intervention: Hopaten acid (40 mg/kg per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol-fentanyl total intravenous anesthesia (TIVA) without hopaten acid
Number of subjects: 40
Study: 20036427

Group type: COMPARATOR
Intervention: 30 mg tranylcypromine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 60 mg tranylcypromine
Number of subjects: 36
Study: 17624978

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus referral to Gamblers Anonymous (GA)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Gamblers Anonymous (GA) referral alone
Number of subjects: 127
Study: 15184959

Group type: EXPERIMENTAL
Intervention: SLP-C (customised corneal-polarisation compensation)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SLP-F (fixed-angle corneal-polarisation compensation)
Number of subjects: 51
Study: 12833248

Group type: EXPERIMENTAL
Intervention: Isokinetic muscle-strengthening exercise
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Isotonic muscle-strengthening exercise
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Isometric muscle-strengthening exercise
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 132
Study: 10796061

Group type: EXPERIMENTAL
Intervention: Immediate Release (IR) formulation of indapamide (2.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sustained Release (SR) formulation of indapamide (1.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sustained Release (SR) formulation of indapamide (1.5 mg) after repeated administration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Immediate Release (IR) formulation of indapamide (2.5 mg) after repeated administration
Number of subjects: 12
Study: 8891006

Group type: EXPERIMENTAL
Intervention: 10% urea ointment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 10
Study: 1795202

Group type: EXPERIMENTAL
Intervention: Quinapril (ACE inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-acting calcium antagonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6337580

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 31403596

Group type: EXPERIMENTAL
Intervention: Mind Over Matter: Healthy Bowels, Healthy Bladder (treatment group)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 121
Study: 27540899

Group type: EXPERIMENTAL
Intervention: PA+SMS group (text messaging cues before PA sessions)
Number of subjects: 49

Group type: COMPARATOR
Intervention: PA group (28-week supervised PA program without SMS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: PA+SMS group
Number of subjects: 49
Study: 25910838

Group type: EXPERIMENTAL
Intervention: Miniaturized cardiopulmonary bypass (MCPB)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass (CCPB)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: MCPB
Number of subjects: 68

Group type: COMPARATOR
Intervention: CCPB
Number of subjects: 68
Study: 21876219

Group type: EXPERIMENTAL
Intervention: Memory screw
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hyrax screw
Number of subjects: 32
Study: 22552194

Group type: EXPERIMENTAL
Intervention: Minimally invasive oesophagectomy
Number of subjects: 115

Group type: COMPARATOR
Intervention: Open oesophagectomy
Number of subjects: 115
Study: 19222610

Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/20 mg
Number of subjects: 618

Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg
Number of subjects: 618
Study: 17710289

Group type: EXPERIMENTAL
Intervention: Dentifrice A (523 microgF/g)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Dentifrice B (1,062 microgF/g)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Dentifrice C (1,373 microgF/g)
Number of subjects: 33
Study: 15156389

Group type: EXPERIMENTAL
Intervention: Memory-shape compression anastomosis clip (CAC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Stapler
Number of subjects: 10
Study: 12577455

Group type: EXPERIMENTAL
Intervention: Parenteral administration of 30 g of alanyl‐glutamine dipeptide (Dipeptiven, Fresenius‐Kabi) from day +1 to day +14 or to discharge from hospital
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isolated control group receiving isonitrogenous glutamine‐free amino acid solution from day +1 to day +14 or to discharge from hospital
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition in dose of 26.5 kcal/kg and 1 g of amino acid/kg given to patients who did not reach adequate oral intake for 5 days
Number of subjects: 40
Study: 10199111

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) titrated to a dose of 0.7 mg/kg
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 8914492

Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control
Number of subjects: 142
Study: 1830259

Group type: EXPERIMENTAL
Intervention: Intranasal insulin delivery (15 units of insulin in 1% sodium glycocholate)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Glycocholate alone (placebo)
Number of subjects: 6
Study: 6858980

Group type: EXPERIMENTAL
Intervention: Suppository group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nonsuppository group
Number of subjects: 84
Study: 31471309

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Baseline CXCL10
Number of subjects: 413
Study: 29795452

Group type: EXPERIMENTAL
Intervention: Video during direct laryngoscopy (VDL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional direct laryngoscopy (TDL)
Number of subjects: 48
Study: 26965165

Group type: EXPERIMENTAL
Intervention: 8-week, group-based, behaviour-change programme with weekly 90-min sessions about healthy eating and physical activity
Number of subjects: 64

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 64
Study: 24633809

Group type: EXPERIMENTAL
Intervention: MNRP1685A (7.5, 15, 24, and 36 mg/kg) with bevacizumab 15 mg/kg every 3 weeks (Arm A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MNRP1685A (12 and 16 mg/kg) with bevacizumab 10 mg/kg every 2 weeks and paclitaxel 90 mg/m(2) weekly (Arm B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of MNRP1685A with bevacizumab
Number of subjects: 24
Study: 24399119

Group type: EXPERIMENTAL
Intervention: IDIProst® Gold (one capsule q24 h) for 3 months
Number of subjects: 129

Group type: COMPARATOR
Intervention: Serenoa repens 320 mg (one capsule q24h) for 3 months
Number of subjects: 129
Study: 20500277

Group type: EXPERIMENTAL
Intervention: Nurse-delivered home visits combined with telephone intervention
Number of subjects: 116

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 116
Study: 17953792

Group type: EXPERIMENTAL
Intervention: Lornoxicam (24 mg day(-1))
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dipyrone (5 g day(-1))
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 16904312

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with vincristine and actinomycin D for 6 weeks
Number of subjects: 205

Group type: COMPARATOR
Intervention: Immediate nephrectomy
Number of subjects: 205
Study: 12829678

Group type: EXPERIMENTAL
Intervention: Bidimensional (BD) measurements
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Unidimensional (UD) measurements
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: WHO criteria for tumor progression
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: WHO criteria for tumor response
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: RECIST criteria for tumor progression
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: RECIST criteria for tumor response
Number of subjects: 33
Study: 10819345

Group type: EXPERIMENTAL
Intervention: Nonavalent protein conjugate pneumococcal vaccine (PnCV)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Inactivated polio vaccine (IPV)
Number of subjects: 207
Study: 9019122

Group type: EXPERIMENTAL
Intervention: Structured diary keeping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured diary keeping and structured recall
Number of subjects: 0
Study: 1394200

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant interleukin 2
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study: 3924065

Group type: EXPERIMENTAL
Intervention: Acipimox (750 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clofibate (2 g/day)
Number of subjects: 20
Study: 30882846

Group type: EXPERIMENTAL
Intervention: Pioglitazone therapy
Number of subjects: 0
Study: 29720113

Group type: EXPERIMENTAL
Intervention: Guideline-driven antiemetic therapy
Number of subjects: 185

Group type: COMPARATOR
Intervention: Single agent antiemetic therapy with haloperidol
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 185
Study: 26746868

Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.5 mg) administered via four monthly intravitreal injections and then as needed per protocol
Number of subjects: 117
Study: 25155371

Group type: EXPERIMENTAL
Intervention: Bevacizumab (Avastin); administered every 4 weeks, pro re nata.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Dexamethasone implant (Ozurdex); administered every 16 weeks, pro re nata.
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both treatments (Bevacizumab and Dexamethasone implant)
Number of subjects: 61
Study: 22368041

Group type: EXPERIMENTAL
Intervention: Proximal esophageal pH capsule
Number of subjects: 22
Study: 20415839

Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen Therapy (HBO(2)T) administered in a course of 20 treatments at pressures between 1.75ATA and 2.5ATA daily for 60-120 min over 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo regimen
Number of subjects: 0
Study: 18541979

Group type: EXPERIMENTAL
Intervention: donepezil (5 mg, n=11 or 10 mg, n=1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo (n=8)
Number of subjects: 20
Study: 16358411

Group type: EXPERIMENTAL
Intervention: Liuwei Dihuang pill (LWDH)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: LWDH
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (Conventional treatment with prednisone and CTX)
Number of subjects: 64
Study: 12869000

Group type: EXPERIMENTAL
Intervention: Custom-made screw implants with plaque control terminated at one implant and continued at the other implant after one month of abutment connection.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Custom-made screw implants with varying periods of plaque accumulation (7, 21, or 90 days).
Number of subjects: 12
Study: 10370915

Group type: EXPERIMENTAL
Intervention: Static foot posture measures (subtalar neutral position, forefoot/rearfoot position, ankle joint dorsiflexion, tibial angle in standing, calcaneal angle in standing)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Dynamic foot posture measures (rearfoot supination and pronation) during the stance phase of gait
Number of subjects: 74

Group type: COMPARATOR
Intervention: Comparison of foot postures between injured and uninjured players
Number of subjects: 74

Group type: COMPARATOR
Intervention: Foot postures comparison based on player position
Number of subjects: 74
Study: 8654639

Group type: EXPERIMENTAL
Intervention: Standardized methods of pituitary desensitization, ovarian stimulation, and IVF‐ET with a maximum of three embryos transferred
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Standardized methods of pituitary desensitization, ovarian stimulation, and IVF‐ET with four or more embryos transferred
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Standardized methods of pituitary desensitization, ovarian stimulation, and IVF‐ET
Number of subjects: 561
Study: 7970453

Group type: EXPERIMENTAL
Intervention: Low-dose RU 486 (5 mg alternate days for four doses, beginning 3 days after the urinary LH surge)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3677558

Group type: EXPERIMENTAL
Intervention: Voluntary isocapnic hyperventilation during exercise
Number of subjects: 9

Group type: COMPARATOR
Intervention: Spontaneous breathing during exercise
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Voluntary isocapnic hyperventilation
Number of subjects: 9
Study: 27676117

Group type: EXPERIMENTAL
Intervention: Miniperc
Number of subjects: 150

Group type: COMPARATOR
Intervention: SWL
Number of subjects: 150
Study: 30538436

Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle risk reduction intervention including sessions with a dietitian, online brain training, and sessions with an exercise physiologist.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control group receiving four online educational modules: dementia literacy and lifestyle risk, Mediterranean diet, cognitive engagement, and physical activity.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle risk reduction intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 0
Study: 26915630

Group type: COMPARATOR
Intervention: Conventional Risk Score (CRS)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Genetic Risk Score (GRS)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: High GRS
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Low GRS
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: (+GRS) group
Number of subjects: 203
Study: 27100654

Group type: EXPERIMENTAL
Intervention: IOL Master 500
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pentacam HR
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: LenStar 900
Number of subjects: 40

Group type: COMPARATOR
Intervention: IOL Master 500, LenStar 900, Pentacam HR
Number of subjects: 40
Study: 23579624

Group type: EXPERIMENTAL
Intervention: Hypertensives (H)
Number of subjects: 45
Study: 21913547

Group type: EXPERIMENTAL
Intervention: Propofol 3.5mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Halothane 3%
Number of subjects: 60
Study: 19803570

Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 758
Study: 17100775

Group type: EXPERIMENTAL
Intervention: Escherichia coli endotoxin (LPS) 20 IU/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: LPS
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: IL-1, IL-6, TNF-alpha
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: IL-10
Number of subjects: 6
Study: 14980101

Group type: EXPERIMENTAL
Intervention: Peg-IFN alpha-2a (Pegasys)
Number of subjects: 202

Group type: COMPARATOR
Intervention: IFN-alpha-2a (Roferon-A)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Genotype 1
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Genotype non-1
Number of subjects: 202
Study: 11317155

Group type: EXPERIMENTAL
Intervention: Clonidine (300 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 10897972

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg daily
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study: 7640038

Group type: EXPERIMENTAL
Intervention: Intensive weekly regimen of cisplatin (70-85 mg/m2)
Number of subjects: 107

Group type: COMPARATOR
Intervention: 3-weekly combination chemotherapy with cisplatin (75 mg/m2)
Number of subjects: 107

Group type: COMPARATOR
Intervention: 3-weekly regimen with cisplatin (20 mg/m2 for 5 days)
Number of subjects: 107
Study: 2502737

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cyclosporin
Number of subjects: 30
Study: 1252671

Group type: EXPERIMENTAL
Intervention: Prostaglandin D2 (10 ng)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prostaglandin D2 (10, 20 and 50 ng)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prostaglandin D2 (100 ng and above)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostaglandin E2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostaglandin D1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostaglandin E1
Number of subjects: 0
Study: 31305282

Group type: EXPERIMENTAL
Intervention: BREASTChoice
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 120
Study: 31395425

Group type: EXPERIMENTAL
Intervention: Prism Adaptation (PA) combined with continuous theta‐burst transcranial magnetic stimulation (cTBS) over the left intact parietal cortex
Number of subjects: 14

Group type: COMPARATOR
Intervention: Prism Adaptation (PA) alone
Number of subjects: 14
Study: 28985813

Group type: EXPERIMENTAL
Intervention: 1 suture + CXL
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2 sutures + CXL
Number of subjects: 20

Group type: COMPARATOR
Intervention: 3 sutures
Number of subjects: 20
Study: 28531469

Group type: EXPERIMENTAL
Intervention: Ezetimibe therapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Flaxseed oil supplementation
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ezetimibe and flaxseed oil supplementation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 23437959

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 20530082

Group type: EXPERIMENTAL
Intervention: Home health education delivered by lay health workers
Number of subjects: 4023

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4023
Study: 19055335

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (once a week for 10 weeks, in addition to conservative treatment with medication)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conservative treatment with medication only (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 30
Study: 16899485

Group type: EXPERIMENTAL
Intervention: Subcutaneous treprostinil
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Subcutaneous treprostinil monotherapy
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Subcutaneous treprostinil in idiopathic pulmonary arterial hypertension (IPAH) patients
Number of subjects: 860

Group type: COMPARATOR
Intervention: Predicted survival
Number of subjects: 860
Study: 12883855

Group type: EXPERIMENTAL
Intervention: Peritoneal drainage (Group I, 70 patients)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No peritoneal drainage (Group II, 70 patients)
Number of subjects: 140
Study: 10663618

Group type: EXPERIMENTAL
Intervention: High-dose IL-2
Number of subjects: 110

Group type: COMPARATOR
Intervention: Low-dose IL-2
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy with idarubicin, ara-C, etoposide
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation
Number of subjects: 110

Group type: COMPARATOR
Intervention: IL-2 treatment arms (high-dose vs low-dose)
Number of subjects: 110
Study: 2135254

Group type: EXPERIMENTAL
Intervention: 3 x 400 mg ibuprofen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 x 600 mg ibuprofen with 2 x 6 mg dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 38965

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 12
Study: 30169605

Group type: EXPERIMENTAL
Intervention: HINE E-GEL®
Number of subjects: 67

Group type: COMPARATOR
Intervention: MEIN®
Number of subjects: 67
Study: 28052915

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of CDCs
Number of subjects: 41

Group type: COMPARATOR
Intervention: Late CDC infusion in controls
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Overall CDC infusion
Number of subjects: 41
Study: 26107818

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) plus standard MMT
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard MMT
Number of subjects: 240
Study: 24406033

Group type: EXPERIMENTAL
Intervention: Self-efficacy-enhancing intervention
Number of subjects: 152

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 152
Study: 21751295

Group type: EXPERIMENTAL
Intervention: Meaning-centered group psychotherapy (MCGP)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 153
Study: 19491860

Group type: EXPERIMENTAL
Intervention: Iron sucrose with EPO
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Iron sucrose without EPO
Number of subjects: 88
Study: 17146695

Group type: EXPERIMENTAL
Intervention: Constant-intensity (CI) cycling
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Freely chosen intensity (FCI) cycling
Number of subjects: 10

Group type: COMPARATOR
Intervention: Variable-intensity (VI) cycling
Number of subjects: 10
Study: 16368038

Group type: EXPERIMENTAL
Intervention: Once-monthly ibandronate 150 mg
Number of subjects: 342

Group type: COMPARATOR
Intervention: Once-weekly alendronate 70 mg
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Once-monthly ibandronate
Number of subjects: 342

Group type: COMPARATOR
Intervention: Once-weekly alendronate
Number of subjects: 342